CRISPR, the Nobel Prize-winning gene editing technology, is poised to have a profound impact on the fields of microbiology and medicine yet again.

A team led by CRISPR pioneers Jennifer Doudna and Jill Banfield has developed a tool to edit the genomes of bacteria-infecting viruses called bacteriophages using a rare form of CRISPR. The ability to easily engineer custom-designed phages will help researchers treat dangerous drug-resistant infections and control microbiomes without antibiotics or harsh chemicals.

Natalia Molchanova, a scientific engineering associate at the Molecular Foundry, works on synthetically produced proteins called peptoids, which have advanced low-cost biotech solutions.